George Cernile, Manager A.I. Technology Group Artificial Intelligence In Medicine Inc. Advancements in Automated Synoptic Reporting.

Slides:



Advertisements
Similar presentations
Professor Adrienne M Flanagan
Advertisements

Mammary ductal carcinoma
Geraldine O’Dowd Consultant Pathologist NHS Lanarkshire 18 th November 2014 Colorectal Cancer Pathology: Impact of new guidelines for the laboratory.
Surgical Pathology of Wide Local Excision of Breast
Breast Pathology Helge Stalsberg MD University Hospital of North Norway.
COMPUTATIONAL INTELLIGENCE FOR THE DETECTION AND CLASSIFICATION OF MALIGNANT LESIONS IN SCREENING MAMMOGRAPHY DATA E. Panourgias,
THE DEVELOPMENT OF SYNOPTIC REPORTS FROM FREE TEXT CONTENT OF ARCHIVAL PATHOLOGY REPORTS GENERATED IN THE ANATOMIC PATHOLOGY LABORATORY INFORMATION SYSTEM.
Histopathology and staging of breast cancer
MCQs On Breast Imaging:
Thorax Breasts.
Thorax Breasts.
Using the EHR for the identification of patients at high risk for hereditary breast and ovarian cancer. Brian Drohan University of Massachusetts 5/30/08.
Microscopically Yours: A Glimpse at our Cells, in Sickness and in Health Nina C. Zanetti Siena College Department of Biology.
Procedures used by CHTN
Breast Pathology Dr. M. Griffin.
AJCC TNM Staging 7th Edition Breast Case #3
Reporting and Management of Early stage Colorectal Cancer Frank Carey Dundee.
NEOPLASIA (Malignant Tumors)
West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.
Chapter 4 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Morphology of breast cancer
Case Study 63: Cancer of the Female Breast
Epidemiological study on INVASIVE BREAST CANCER treated at Hotel Dieu de France Hospital University of Saint-Joseph Faculty of Medicine Gerard Abadjian,
Clinico-Pathological Conference (CPC) Meet Karpagam Medical College Hospital
Neoplasia. 3- Rate of growth  Most benign tumours grow slowly over a period of years, whereas most cancers grow rapidly, spread locally and to distant.
Aaron Scholnik, M.D., P.K. Pathak, Ph.D., Principal Investigators John McPhail, (Project Manager), Renu Pandit, M.D., Asif Masood, M.D., Department of.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
CANCER BREAST OVERVIEW Dr. Ehab M.Oraby. INTRODUCTION  Breast is a modified sweat gland between skin and pectoral fascia.
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
1 Preclinical-Bench Testing II Using Human Observers to Objectively Measure and Evaluate Imaging Performance of Digital WSI Systems Max Robinowitz, MD.
EVALUATION OF LYMPH NODES & PATHOLOGIC EXAMINATION FOR BREAST CASES Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry.
Metastatic Cancer – Gross Pathology Lymph node - metastasis from breastLiver – metastasis from lung Vertebral column – metastasis from prostate Mesentery.
Microwave Radiometry Microwave Radiometry. The RTM-01-RES radiometer receives and evaluates the natural electromagnetic radiation (temperature) from the.
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
Reporting of Skin cancer using RCPath Standards. A regional perspective. Paul Barrett.
AJCC 6 TH EDITION STAGING OF BREAST CARCINOMA. AJCC NODE STAGING -16 CATEGORIES pNX – 1 option pN0 – 5 options; null,(i-),(i+),(mol-),(mol+) pN1 – 4.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Erwin Hernandez Seng Thai Phou Trang Pham Shane Manalang Y Dinh.
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
RENAL TUMORS Renal BlockPathology Dept, KSU Renal Practical III.
Surgical Oncology Surgical Oncology 05/13/12 – 05/19/2012 David Williams Andy Young Ashley Limkemann Yula Dzhashiashvili.
Radiotherapy Protocols Bristol protocol version 12.
Pathology.
Information Extraction for Clinical Data Mining: A Mammography Case Study H. Nassif, R. Woods, E. Burnside, M. Ayvaci, J. Shavlik and D. Page University.
W. Scott Campbell, Ph.D., MBA University of Nebraska Medical Center
From Qualitative to Quality Impact Heather Bryant, MD, PhD Health System Use Summit February, 2016.
Electronic CAP Cancer Checklists and Cancer Registries – A Pilot Project 2009 NAACCR Conference Ken Gerlach, MPH, CTR Castine Verrill, MS, CTR CDC-National.
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
PATHOLOGY OF NECK DISSECTION. VIEW FROM DEEP ASPECT OF NECK DISSECTION.
NPCR Data Completeness and Quality Audits Review of: Collaborative Stage and Surgery Data Mary Lewis, CTR NPCR Program Consultant.
Oncology in SNOMED CT NCI Workshop The Role of Ontology in Big Cancer Data Session 3: Cancer big data and the Ontology of Disease Bethesda, Maryland May.
Diseases of the prostate Osvaldo Rubinstein, MD. Normal urinary bladder with right and left ureters.
Adenoma of the ampulla of vater
Measuring Coding Accuracy Artificial Intelligence in Medicine National Cancer Institute.
SNOMED CT and Surgical Pathology
W. Scott Campbell, MBA, PhD James R. Campbell, MD
Hematology and Pathology Devices Panel Meeting October 22-23, 2009
SNOMED CT and Surgical Pathology
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
NEOPLASIA (Malignant Tumors)
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Current Status of Breast Ultrasound
Avoiding Pitfalls in Mammographic Interpretation
Treatment Overview: The Multidisciplinary Team
Yukihiro Hama, Yoshinori Koyama, Yasuteru Urano, Peter L
Presentation transcript:

George Cernile, Manager A.I. Technology Group Artificial Intelligence In Medicine Inc. Advancements in Automated Synoptic Reporting

Synoptex technologyPerformance measuresSynoptex enhancementsUses of synoptic dataCAP checklists Slide 2

11 June Synoptic Report CLINICAL HISTORY/MACROSCOPY Right mastectomy and axillary tissue. A right mastectomy specimen with overlying skin measuring 220mm x 85mm and underlying breast tissue measuring 220mm x 100mm x 70mm. The axillary tail measures 125 x 60mm. The nipple is slightly retracted and located centrally. The superior margin is painted red, the inferior margin painted green and the deep cut margin is painted blue. Cut sections of the underlying breast tissue shows an ill-defined grey white yellow lesion with patchy areas of haemorrhage measuring 35 x 35 x 35mm located immediately below the nipple, 20mm from the inferior margin, 45mm from the deep cut margin, 50mm from the superior margin, 85mm from the medial margin and 100mm from the lateral cut margin. A1 - nipple, B1 - upper outer quadrant, C1 - upper inner quadrant, D1 - lower outer quadrant, E1 - lower inner quadrant, F1, G1 - tumour composite blocks, H1, I1 - tumour composite blocks, J1 - deep cut margin, K1 - superior margin, L1 – inferior margin, M4 - lymph nodes, N4 - lymph nodes, O - 3 serial slices, lymph node, P - 3 lymph nodes. MICROSCOPY This right mastectomy specimen demonstrates an invasive ductal carcinoma with the following pathological features: TUMOUR HISTOLOGY & GRADE The tumour is of an infiltrating poorly differentiated ductal carcinoma of non-otherwise specified type. The tumour is poorly defined and extremely infiltrative, comprising poorly-formed tubules, nests or strands of cuboidal tumour cells displaying high grade nuclei. The tumour cells are set within fibrotic desmoplastic stroma. Many lactiferous ducts are entrapped within the tumour. Frequent tumour mitoses are seen. Microcalcification is seen in some neoplastic tubules. Tumour grade (Modified Bloom-Richardson Scoring System): Tubular formation: 3 Nuclear atypia: 3 Tumour mitoses: 2 Total score: 8 (Grade III) TUMOUR LOCATION, SIZE AND EXTENT The tumour is located 5mm below the nipple and has a macroscopic size of 35mm across. The border of the tumour is poorly circumscribed and infiltrative. INTRA-LYMPHOVASCULAR OR PERINEURAL TUMOUR PERMEATION Focal intralymphatic tumour permeation is noted. No perineural tumour invasion is seen in sections submitted.

11 June CLINICAL HISTORY/MACROSCOPY Right mastectomy and axillary tissue. A right mastectomy specimen with overlying skin measuring 220mm x 85mm and underlying breast tissue measuring 220mm x 100mm x 70mm. The axillary tail measures 125 x 60mm. The nipple is slightly retracted and located centrally. The superior margin is painted red, the inferior margin painted green and the deep cut margin is painted blue. Cut sections of the underlying breast tissue shows an ill-defined grey white yellow lesion with patchy areas of haemorrhage measuring 35 x 35 x 35mm located immediately below the nipple, 20mm from the inferior margin, 45mm from the deep cut margin, 50mm from the superior margin, 85mm from the medial margin and 100mm from the lateral cut margin. A1 - nipple, B1 - upper outer quadrant, C1 - upper inner quadrant, D1 - lower outer quadrant, E1 - lower inner quadrant, F1, G1 - tumour composite blocks, H1, I1 - tumour composite blocks, J1 - deep cut margin, K1 - superior margin, L1 – inferior margin, M4 - lymph nodes, N4 - lymph nodes, O - 3 serial slices, lymph node, P - 3 lymph nodes. MICROSCOPY This right mastectomy specimen demonstrates an invasive ductal carcinoma with the following pathological features: TUMOUR HISTOLOGY & GRADE The tumour is of an infiltrating poorly differentiated ductal carcinoma of non-otherwise specified type. The tumour is poorly defined and extremely infiltrative, comprising poorly-formed tubules, nests or strands of cuboidal tumour cells displaying high grade nuclei. The tumour cells are set within fibrotic desmoplastic stroma. Many lactiferous ducts are entrapped within the tumour. Frequent tumour mitoses are seen. Microcalcification is seen in some neoplastic tubules. Tumour grade (Modified Bloom-Richardson Scoring System): Tubular formation: 3 Nuclear atypia: 3 Tumour mitoses: 2 Total score: 8 (Grade III) TUMOUR LOCATION, SIZE AND EXTENT The tumour is located 5mm below the nipple and has a macroscopic size of 35mm across. The border of the tumour is poorly circumscribed and infiltrative. INTRA-LYMPHOVASCULAR OR PERINEURAL TUMOUR PERMEATION Focal intralymphatic tumour permeation is noted. No perineural tumour invasion is seen in sections submitted. Synoptic Report

Manual extraction of Synoptic data from text min. per report Manual extraction with Synoptex Assist 2 min. per report Fully automated extraction 2 – 3 seconds per report Slide 5

Data can be found in many formats Data aggregate detection Pattern matching Heuristics for logical consistency Language processing Slide 6 Specimen type : Hemicolectomy, right, partial excision of urinary bladder, and salpingo-oophorectomy, right Orientation Clinical information : Colon, right Anatomical landmarks : Ileum = proximal Surgical markings : Absent Pathlogy markings : Ink = margins of urinary bladder wall Ileum, terminal Length : 8 cm Serosa : Unremarkable Wall : Thickness: 0.4 cm Mucosa : Slightly edematous Vermiform appendix : Absent Colon, right Length : 22 cm Serosa : Cecum: Puckering and attached portion of urinary bladder wall and right adnexa (see below) Otherwise: Unremarkable Wall : Thickness: 0.4 cm Mucosa : Tumour: - Location: Ileocecal valve - Configuration: Fungating - Size: - Length: 7 cm - Width: 12 cm - Thickness: 7 cm - Extent of invasion: Urinary bladder - Margins: - Proximal: 8 cm - Distal: 15 cm - Radial: 0.1 cm` Non-neoplastic colon: Unremarkable Specimen type : Hemicolectomy, right, partial excision of urinary bladder, and salpingo-oophorectomy, right Orientation Clinical information : Colon, right Anatomical landmarks : Ileum = proximal Surgical markings : Absent Pathlogy markings : Ink = margins of urinary bladder wall Ileum, terminal Length : 8 cm Serosa : Unremarkable Wall : Thickness: 0.4 cm Mucosa : Slightly edematous Vermiform appendix : Absent Colon, right Length : 22 cm Serosa : Cecum: Puckering and attached portion of urinary bladder wall and right adnexa (see below) Otherwise: Unremarkable Wall : Thickness: 0.4 cm Mucosa : Tumour: - Location: Ileocecal valve - Configuration: Fungating - Size: - Length: 7 cm - Width: 12 cm - Thickness: 7 cm - Extent of invasion: Urinary bladder - Margins: - Proximal: 8 cm - Distal: 15 cm - Radial: 0.1 cm` Non-neoplastic colon: Unremarkable

Slide 7

Slide 8

Synoptex technologyPerformance measuresSynoptex enhancementsUses of synoptic dataCAP checklists Slide 9

How often does Synoptex return the expected value? How often does Synoptex return a non-expected value? Is there a tradeoff between completeness and accuracy? How does Synoptex improve with new iterations? Slide 10

Sensitivity and Specificity measure the performance of a binary classification system  Present/Not present  True/False In the Synoptex case, this could only be applied to a single value, for example histologic type Need a new method to evaluate Synoptex that is analogous to Sensitivity and Specificity Sensitivity and Specificity? Synoptex has many variables and many checklists Slide 11

Build a manual reference data set Define three measures from the manually reviewed reference data Slide 12 C= Correct: Sum of correctly returned values by Synoptex. ∑ (all correctly found values) I= Incorrect: Sum of incorrectly returned values by Synoptex ∑ (all incorrect values) M= Missed: Sum of values the were missed by Synoptex ∑ (all missed values)

Define two new concepts with the variables Slide 13 Required Correct + Missed = C + M Returned Correct + Incorrect = C + I C = Correct (all correct values) I = Incorrect (all incorrect values) M = Missed (all missed values)

Completeness Correct / Required= C / (C + M) The ability to find the correct data when it is in the path report. Accuracy Correct / Returned= C / (C + I) The ability to find only the correct data when it is in the path report. Accuracy can be seen as a measure of exactness or fidelity. C = Correct I = Incorrect M = Missed Sensitivity Specificity

Completeness 81.2% average Accuracy 82.0% average

Completeness 93.4% average Accuracy 93.8% average

Synoptex technologyPerformance measuresSynoptex enhancementsUses of synoptic dataCAP checklists Slide 17

Add new elements, e.g.: HER2, ER, PR New template definitions Expand or modify Sites / Templates Concepts / data items Expressions Synonyms Modify standard expressions for data items How do we expand capabilities of Synoptex system Slide 18

Slide 19

Slide 22

Synoptex technologyPerformance measuresSynoptex enhancementsUses of synoptic dataCAP checklists Slide 23

Standardization of Pathology Reports for Registries Data Quality Assessments Audits Mining of Current and Legacy Data Export of Indexed Data for Statistical Processing Annotated Datasets for Biospecimen Repositories Data for Automated Record Matching –Clinical Trials –Case Control Studies Slide 24

Slide 25 Range % ReportsWeighted Data Site: Breast Reports Sample Size: Date Range: No. Of Cancer Reports: 8422 No. Of Breast Cancers: 1678 Element Analysis Data Element Report CountWeight Specimen Type Lymph Node Sampling895 1 Specimen Size Tumor Laterality Tumor Site775 0 Tumor Size996 1 Histologic Type Grading System779 0 Pathologic Staging (pTNM)511 0 Margins901 1 Lymphatic Invasion838 0 Microcalcifications759 0 Additional Pathologic Findings885 0 Tubule Formation741 1 Nuclear Pleomorphism Mitotic Count792 1 Histologic Grade Extent of Margin Involvement for Invasive Ca Extent of Margin Involvement for DCIS10 0 HER2 Status570 0 ER Status PR Status Lymph Nodes Positive449 1 Lymph Nodes Examined618 1

Slide ER + - HER (61%) 148 (68%) (61%) ER Positive %

Synoptex technologyPerformance measuresSynoptex enhancementsUses of synoptic dataCAP checklists Slide 27

CAP Checklists version updates Slide 28 How frequently are they updated? How do we manage updates/versions? How can systems be maintained ? How can custom additions be kept across versions?

Slide 29

Slide 30

Interoperability Synoptex output same format as Manual checklists  SNOMED codes  CKEYS Synoptex data can be viewed with STS checklist system Slide 31

Export Synoptic Database Synoptic Database Export

Import Export Synoptic Database Checklist Converter

Renders Pathology Reports Machine Readable – Facilitates Research Identifies Some Collaborative Stage Elements Saves Labor in Deriving Synoptic Reports – both manually and fully automated Verifies Report Content (Audits) Compare reporting accuracy hospital-to-hospital Apply Synoptex to other data sources – Surgical reports – Medical records – Radiology reports – Hematology reports Slide 34

Thank You Slide 35